129 related articles for article (PubMed ID: 35356627)
1. Molecular Characteristics and Prognostic Role of MFAP2 in Stomach Adenocarcinoma.
Tang F; Hu C; Long Z; Liu Y; Li G
J Healthc Eng; 2022; 2022():1417238. PubMed ID: 35356627
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Bioinformatic Analysis of NOTCH Pathway Involvement in Stomach Adenocarcinoma.
Xue D; Li D; Dou C; Li J
Dis Markers; 2021; 2021():4739868. PubMed ID: 34925644
[TBL] [Abstract][Full Text] [Related]
4. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
[TBL] [Abstract][Full Text] [Related]
5. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
6. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
Zha Z; Zhang P; Li D; Liu G; Lu L
Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the immune and prognostic implication of MASP1 in stomach adenocarcinoma.
Zhang CH; Xu ZQ; Peng LL; Wang JJ; Gu HT
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6725-6741. PubMed ID: 36196721
[TBL] [Abstract][Full Text] [Related]
8. The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma.
Huang Z; He A; Wang J; Lu H; Zhang R; Wu L; Feng Q
Aging (Albany NY); 2021 Jun; 13(12):16637-16655. PubMed ID: 34162762
[TBL] [Abstract][Full Text] [Related]
9. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
Guo L; Liu D
Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
[TBL] [Abstract][Full Text] [Related]
10. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
[TBL] [Abstract][Full Text] [Related]
11. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
12. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
[TBL] [Abstract][Full Text] [Related]
14. Independent prognostic implications of
Ma C; Luo H; Cao J; Gao C; Fa X; Wang G
J Cancer; 2020; 11(23):7009-7022. PubMed ID: 33123291
[No Abstract] [Full Text] [Related]
15. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.
Zheng X; Li Y; Ma C; Zhang J; Zhang Y; Fu Z; Luo H
Biomed Res Int; 2020; 2020():8851437. PubMed ID: 33178836
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Novel Prognosis Prediction Model for Patients With Stomach Adenocarcinoma.
Wang T; Wen W; Liu H; Zhang J; Zhang X; Wang Y
Front Med (Lausanne); 2021; 8():793401. PubMed ID: 35004767
[No Abstract] [Full Text] [Related]
17. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
Shi Y; Chen Z; Gao J; Wu S; Gao H; Feng G
Oncol Rep; 2018 Oct; 40(4):2014-2022. PubMed ID: 30106437
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
[TBL] [Abstract][Full Text] [Related]
20. FKBP10 functioned as a cancer-promoting factor mediates cell proliferation, invasion, and migration via regulating PI3K signaling pathway in stomach adenocarcinoma.
Wang RG; Zhang D; Zhao CH; Wang QL; Qu H; He QS
Kaohsiung J Med Sci; 2020 May; 36(5):311-317. PubMed ID: 31868996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]